Search research articles
Contact Us
Filters
Showing results (181-190 of 307) with videos related to
Page
of 31
Sort By:
Cancer Research
|
February 15, 1997
Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer
V B Lokeshwar, C Obek, M S Soloway, et al.
Urology
|
May 1, 1989
Prognostic factors in patients with advanced prostate cancer
M S Soloway, S Ishikawa, R van der Zwaag, et al.
Cancer
|
May 15, 1984
The stability and antitumor activity of recycled (intravesical) mitomycin C
S C Hopkins, R G Buice, R Matheny, et al.
The Journal of Urology
|
June 1, 1982
Circadian and day-to-day variation of prostatic acid phosphatase
I Nissenkorn, D D Mickey, D B Miller, et al.
Journal of Chemotherapy (Florence, Italy)
|
July 1, 1989
M-VAC regimen in murine bladder tumors
M Brausi, D P Hickey, A F Blatnik, et al.
Urology
|
January 1, 1994
Stage T1A carcinoma of prostate
H Matzkin, J P Patel, J E Altwein, et al.
Prostate Cancer and Prostatic Diseases
|
September 15, 2010
Comparison of urologist reimbursement for managing patients with low-risk prostate cancer by active surveillance versus total prostatectomy
M Manoharan, A Eldefrawy, D Katkoori, et al.
Urology
|
January 14, 1999
Intravesical therapy for transitional cell carcinoma of the bladder: the community practice
C Obek, S W Shelfo, H J Korman, et al.
Urology
|
April 1, 1984
Chemotherapy of murine bladder cancer: in vitro and in vivo
H B Niell, M S Soloway, R B Matheny, et al.
Urology
|
February 1, 1982
Single and sequential combination intravesical chemotherapy of murine bladder cancer
M S Soloway, I Nissenkorn, L W McCallum, et al.
Page
of 31
Search research articles
Search
Showing results (181-190 of 307) with videos related to
Sort By:
Page
of 31
Cancer Research
|
February 15, 1997
Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer
V B Lokeshwar, C Obek, M S Soloway, et al.
Urology
|
May 1, 1989
Prognostic factors in patients with advanced prostate cancer
M S Soloway, S Ishikawa, R van der Zwaag, et al.
Cancer
|
May 15, 1984
The stability and antitumor activity of recycled (intravesical) mitomycin C
S C Hopkins, R G Buice, R Matheny, et al.
The Journal of Urology
|
June 1, 1982
Circadian and day-to-day variation of prostatic acid phosphatase
I Nissenkorn, D D Mickey, D B Miller, et al.
Journal of Chemotherapy (Florence, Italy)
|
July 1, 1989
M-VAC regimen in murine bladder tumors
M Brausi, D P Hickey, A F Blatnik, et al.
Urology
|
January 1, 1994
Stage T1A carcinoma of prostate
H Matzkin, J P Patel, J E Altwein, et al.
Prostate Cancer and Prostatic Diseases
|
September 15, 2010
Comparison of urologist reimbursement for managing patients with low-risk prostate cancer by active surveillance versus total prostatectomy
M Manoharan, A Eldefrawy, D Katkoori, et al.
Urology
|
January 14, 1999
Intravesical therapy for transitional cell carcinoma of the bladder: the community practice
C Obek, S W Shelfo, H J Korman, et al.
Urology
|
April 1, 1984
Chemotherapy of murine bladder cancer: in vitro and in vivo
H B Niell, M S Soloway, R B Matheny, et al.
Urology
|
February 1, 1982
Single and sequential combination intravesical chemotherapy of murine bladder cancer
M S Soloway, I Nissenkorn, L W McCallum, et al.
Page
of 31